Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Clinical trial NCT05580861 · RECRUITING
Trial details
- NCT number
- NCT05580861
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2025-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.